Emerging Psilocybin Therapy for End-of-Life Distress
Insights into a new study exploring risks, benefits, and applications for advanced cancer patients
Topline
A recent human study highlights both the potential benefits and the notable risks of psilocybin and other hallucinogens in patients facing end-of-life psychological distress, especially among those with advanced cancer and existing comorbidities. While these substances show promise for improving mood and quality of life in carefully controlled cl…
Keep reading with a 7-day free trial
Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.